ClassID:

20599

A61K35/00 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Recent Application in this class:
#301
20170007691
2017-01-12

Composition for inducing proliferation or accumulation of regulatory T cells

#302
20160354401
2016-12-08

Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells

#303
20160346314
2016-12-01

Composition and method for promoting reduction of heat stress in animals

#304
20160279068
2016-09-29

MICROPARTICLES, METHODS FOR THEIR PREPARATION AND USE

#305
20160279059
2016-09-29

Ultrasound-triggerable agents for tissue engineering

#306
20160256604
2016-09-08

Tunable covalently crosslinked hydrogels and methods of making the same

#307
20160228469
2016-08-11

Method of preparing autologous cells and methods of use for therapy

#308
20160213896
2016-07-28

Hydrodynamic method and apparatus for delivering fluids to kidney tissues

#309
20160213027
2016-07-28

PET FOOD ADDITIVE

#310
20160209417
2016-07-21

Methods of diagnosing, classifying and treating endometrial cancer and precancer

#311
20160199419
2016-07-14

Biomolecular group related to cell anti-aging

#312
20160186259
2016-06-30

Gene and protein expression properties of adherent stromal cells cultured in 3D

#313
20160175370
2016-06-23

Targeting of herpes simplex virus to specific receptors

#314
20160169870
2016-06-16

Method for diagnosis of diseases using morphological characteristics of luterial

#315
20160158147
2016-06-09

Composition and method for orally administering one or more active agents to a pet

#316
20160151430
2016-06-02

Composition for inducing proliferation or accumulation of regulatory T cells

#317
20160143960
2016-05-26

Composition for inducing proliferation or accumulation of regulatory T cells

#318
20160128961
2016-05-12

DIETARY OMEGA-3 FATTY ACID DERIVED GLYCEROPHOSPHOLIPIDS TO TREAT NEUROPATHIC PAIN

#319
20160115449
2016-04-28

Method for producing differentiated cells

#320
20160083462
2016-03-24

Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same

#321
20160053021
2016-02-25

Regulating transplant rejection of donor and embryonic stem cell-derived tissues and organs

#322
20160051683
2016-02-25

Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan

#323
20160015671
2016-01-21

Pharmaceutical composition containing 8 triglycerides, and preparations and use thereof

#324
20150374736
2015-12-31

Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells

#325
20150320807
2015-11-12

Strain of ssp.

#326
20150320805
2015-11-12

Composition for inducing proliferation or accumulation of regulatory T cells

#327
20150224198
2015-08-13

Lyophilized viral formulations

#328
20150218518
2015-08-06

Industrial preparations of natural killer (NK) cells and injections containing NK cells

#329
20150216905
2015-08-06

Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

#330
20150209387
2015-07-30

Method for inducing immune tolerance using non-proliferative polymer-modified allogeneic leukocytes

#331
20150202299
2015-07-23

Stabilizing shear-thinning hydrogels

#332
20150202286
2015-07-23

Toxicity Management for Anti-Tumor Activity of CARs

#333
20150196597
2015-07-16

Acellular pro-tolerogenic compositions for treatment/prevention of graft rejection

#334
20150191526
2015-07-09

Cell line expressing single chain factor VIII polypeptides and uses thereof

#335
20150175968
2015-06-25

Methods for producing cartilage and bone

#336
20150174168
2015-06-25

Acellular pro-tolerogenic compositions and process for making same

#337
20150164954
2015-06-18

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

#338
20150164948
2015-06-18

Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases

#339
20150157665
2015-06-11

Pathogen-inactivated red blood cell compositions

#340
20150118220
2015-04-30

Food for nutritional therapy of AIDS

#341
20150118200
2015-04-30

Production of extracellular matrix, conditioned media and uses thereof

#342
20150056290
2015-02-26

Microsphere compositions, preparation method and applications thereof

#343
20150023923
2015-01-22

Methods for promoting neuronal development and/or health

#344
20150004145
2015-01-01

Methods for programming differentiated cells into hematopoietic stem cells

#345
20140335056
2014-11-13

Sustained releasing pharmaceutical composition

#346
20140331341
2014-11-06

Transgenic comprising a human protein with a tendency to aggregate fused to a fluorescent protein

#347
20140328802
2014-11-06

Strain of

#348
20140315305
2014-10-23

Method for producing corneal endothelial cell

#349
20140294793
2014-10-02

GPR15-mediated homing and uses thereof

#350
20140205540
2014-07-24

Method of Improving Balance

#351
20140106059
2014-04-17

Solventless mixing process for coating pharmaceutical ingredients

#352
20140105923
2014-04-17

Tumor antigen proteins or genes of polo-like kinase 1

#353
20140072637
2014-03-13

Treatment for bone formation disorders by growth factor delivery

#354
20140057281
2014-02-27

Method of producing retinal pigment epithelial cell sheet

#355
20140017218
2014-01-16

Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes

#356
20130344114
2013-12-26

COMPOSITION FOR REPAIRING CARTILAGE TISSUE AND METHOD FOR MAKING THE SAME

#357
20130294983
2013-11-07

Methods and apparatus for isolating platelets from blood

#358
20130172371
2013-07-04

Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K and mTOR in combination with autophagy inhibitors

#359
20130164378
2013-06-27

Special Prenatal Nutritional Supplement and Design Method Thereof

#360
20120251505
2012-10-04

HUMAN LYMPHOID TISSUE INDUCER (LTi) CELL COMPOSITIONS AND METHODS OF USE

#361
20120238023
2012-09-20

Method for producing differentiated cells

#362
20120230890
2012-09-13

Method and apparatus for isolating platelets from blood

#363
20120219737
2012-08-30

Production of extracellular matrix, conditioned media and uses thereof

#364
20120207790
2012-08-16

IMMUNOSUPPRESSING AGENT COMPRISING MESENCHYMAL STEM CELL DERIVED FROM ADIPOSE TISSUE, AND USE THEREOF

#365
20120183622
2012-07-19

ENCAPSULATED CELLS AND COMPOSITES THEREOF

#366
20120171695
2012-07-05

Spontaneously contracting fish cell aggregates, use thereof and method for the production thereof

#367
20120164308
2012-06-28

Bovine meat compositions having enhanced quality, nutritive and health values obtained from enrichment diets

#368
20120141528
2012-06-07

Lyophilized viral formulations

#369
20120134970
2012-05-31

Viral vectors encoding multiple highly homologus non-viral polypeptides and the use of same

#370
20120128741
2012-05-24

Modified hyaluronic acid polymer compositions and related methods

#371
20120064572
2012-03-15

Bacterial virulence factors and uses thereof

#372
20110286987
2011-11-24

Quenching methods for red blood cell pathogen inactivation

#373
20110217268
2011-09-08

Therapy or prophylaxis of infections with a lytic bacteriophage specifically against the

#374
20110158957
2011-06-30

Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

#375
20110154510
2011-06-23

Automated high-content live animal drug screening using

#376
20110142810
2011-06-16

CELL PREPARATION FOR BONE TISSUE REGENERATION

#377
20110065183
2011-03-17

Methods and apparatus for isolating platelets from blood

#378
20110039765
2011-02-17

Bioactive Molecules Produced by Probiotic Bacteria

#379
20110008397
2011-01-13

Compartmental extract compositions for tissue engineering

#380
20110008310
2011-01-13

Methods and compositions for mitochondrial replacement therapy

#381
20110008293
2011-01-13

Device and method for preparing microparticles

#382
20100291046
2010-11-18

Equine progenitor cells

#383
20100278789
2010-11-04

METHODS OF GENERATING EXPANDED AND RE-DIFFERENTIATED ADULT ISLET BETA CELLS CAPABLE OF PRODUCING INSULIN

#384
20100278783
2010-11-04

Method of preparing autologous cells and method of use for therapy

#385
20100266556
2010-10-21

Method for expanding hematopoietic stem cells using heterocyclic compound

#386
20100234296
2010-09-16

FOOD MATERIAL FOR INHIBITING OSTEOCLASTOGENESIS

#387
20100086529
2010-04-08

METHODS OF MAKING CONCENTRATED FIBRINOGEN- AND PLATELET-CONTAINING COMPOSITIONS

#388
20100034892
2010-02-11

TREATMENT FOR BONE FORMATION DISORDERS BY GROWTH FACTOR DELIVERY

#389
20090324554
2009-12-31

METHOD FOR INHIBITING OR TREATING A DISEASE ASSOCIATED WITH INTRACELLULAR FORMATION OF PROTEIN FIBRILLAR OR AGGREGATES

#390
20090258045
2009-10-15

STRUCTURES INCLUDING ANTIMICROBIAL PEPTIDES

#391
20090238806
2009-09-24

TREATMENT OF INTERVERTEBRAL DISC DEGENERATION

#392
20090220461
2009-09-03

Metastasis inhibition preparations and methods

#393
20090162935
2009-06-25

VACCINIA VIRUS HOST RANGE GENES TO INCREASE THE TITER OF AVIPOXVIRUSES

#394
20090136452
2009-05-28

Targeting of herpes simplex virus to specific receptors

#395
20090130173
2009-05-21

Bone matrix compositions and methods

#396
20090101599
2009-04-23

Methods and apparatus for isolating platelets from blood

#397
20090061013
2009-03-05

Methods of enhancing the quality, nutritive and health values of meat from bovine

#398
20090014391
2009-01-15

Buoy suspension fractionation system

#399
20080226598
2008-09-18

Compositions and methods for generating an immune response utilizing alphavirus-based vector systems

#400
20080213295
2008-09-04

HER-2/neu fusion proteins

#401
20080213234
2008-09-04

USE OF OSTEOPONTIN FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGIC DISEASES

#402
20080194700
2008-08-14

Use of paeonol for inhibiting angiogenesis or for enhancing radiosensitization

#403
20070243233
2007-10-18

Bioactive-rich concentrates and nutritive and therapeutic products containing same

#404
20070225214
2007-09-27

USE OF OSTEOPONTIN FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGIC DISEASES

#405
20070117180
2007-05-24

Enzyme producing plasma protein fragment having inhibitory activity to metastasis and growth of cancer and plasma protein fragment produced by fragmentation by said enzyme

#406
20070053919
2007-03-08

Compositions including different types of transfer factor

#407
20070041997
2007-02-22

Bacterial virulence factors and uses thereof

#408
20070034579
2007-02-15

Methods and apparatus for isolating platelets from blood

#409
20070031367
2007-02-08

Composition and method for neck skin firming

#410
20060210524
2006-09-21

SKIN CARE COMPOSITION

#411
20060160724
2006-07-20

Preserving a hemoglobin blood substitute with a transparent overwrap

#412
20060067948
2006-03-30

Viral vectors

#413
20060039928
2006-02-23

Isolated avian cell that expresses Vaccinia virus host range genes

#414
20060029581
2006-02-09

Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

#415
20050196874
2005-09-08

Methods and apparatus for isolating platelets from blood

#416
20050186120
2005-08-25

Methods and apparatus for isolating platelets from blood

#417
20050176639
2005-08-11

Use of osteopontin for the treatment and/or prevention of neurologic diseases

#418
20050058716
2005-03-17

Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions

#419
20050058664
2005-03-17

Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains

#420
16254624
2019-10-15

Antibodies binding OX40 and uses thereof